✦ LIBER ✦

Comparison of the tumor markers CA 19–9, CA 12–5, CA 15–3 and CA 50

✍ Scribed by C. Dienst; F. -G. Hanisch; G. Uhlenbruck

Book ID: 112785574
Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 149 KB
Volume: 111
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf02580125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma concentrations of CA 50,CA 12.5,C

Plasma concentrations of CA 50,CA 12.5,CA 15.3 and CA 19.9 in endometrial cancer

✍ S. Huber; P. Schmidt-Rhode; K.-D. Schulz; G. Sturm 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Evaluation of five glycoprotein tumour m

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma

✍ Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

Increased levels of glycoprotein tumour markers have been observed in sera of patients with renal-cell carcinoma. Five different glycoprotein markers [carcinoembryonic antigen (CEA), CA-50, CA-19-9, CA-125 and CA-15-3] were assessed in 154 consecutive patients with renal-cell carcinoma before initia

Significance of Serum Tumor Markers Carc

Significance of Serum Tumor Markers Carcinoembryonic Antigen, CA 19-9, CA 125, and CA 15-3 in Pre-Orthotopic Liver Transplantation Evaluation

✍ A. Pissaia Jr; D. Bernard; O. Scatton; O. Soubrane; F. Conti; Y. Calmus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Serum ca 50 as a tumor marker in pancrea

Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9

✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different

Evaluation of seven tumor markers (CA 50

Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma

✍ T. Wobbes; C. M. G. Thomas; M. F. G. Segers; F. M. Nagengast 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 1 views

Tumor markers carcinoembryonic antigen,

Tumor markers carcinoembryonic antigen, CA 50, and CA 19-9 and squamous cell carcinoma of the esophagus pretreatment screening

✍ Eva Munck-Wikland; Richard Kuylenstierna; Britta Wahren; Johan Lindholm; Stig Ha 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

Pretreatment serum levels of the tumor markers carcinoembryonic antigen (CEA), CA 50, and CA 19-9 in 95 patients with squamous cell carcinoma of the esophagus and 32 age-matched controls were compared. Thirty-nine percent of the cancer patients showed elevated ( 2 5 Wgg/l) serum CEA levels, 41% had